AcuFocus Inc. is a privately held ophthalmic medical device company that develops and markets breakthrough technologies for the improvement of near vision. The Company's proven, proprietary technology platform uses a small aperture - or pinhole - effect to allow focused light rays to reach the retina and bring objects into focus. The result is unique, reliable and long-term. Using this small aperture concept, two products have been developed: the Company's flagship product, the KAMRA™ corneal inlay, and the innovative IC-8™ IOL. The KAMRA inlay helps presbyopic patients restore their near vision while maintaining their distance vision. The IC-8 IOL* provides a range of vision across various distances, from near to far, and is specifically designed for patients with cataracts. In addition to these products, AcuFocus also distributes the AcuTarget HD™ diagnostic and surgical planning instrument. This instrument is essential for the optimal treatment and technology selection for a broad range of patients, including LASIK, cataract, dry eye and presbyopes.
Company Growth (employees)
Irvine, US
Size (employees)
66 (est)
AcuFocus was founded in 2001 and is headquartered in Irvine, US

Key People/Management at AcuFocus

Jason Tester

Jason Tester

Dan Siems

Dan Siems

Charles E. Larsen

Charles E. Larsen

Nick Tarantino

Nick Tarantino

Chief Global Clinical and Regulatory Officer

AcuFocus Office Locations

AcuFocus has an office in Irvine
Irvine, US (HQ)
200 32 Discovery
Show all (1)

AcuFocus Financials and Metrics

Summary Metrics

Founding Date


Total Funding

$170 m

Latest funding size

$66 m

Time since last funding

over 1 year


AcuFocus's latest funding round in September 2016 was reported to be $66 m. In total, AcuFocus has raised $170 m

AcuFocus's Web-traffic and Trends

AcuFocus Online and Social Media Presence

AcuFocus Company Life and Culture

You may also be interested in